StEP Ignite 2024: OUI programme supports students building start-ups
The team behind MariTest, a non-invasive test for malaria, are the winners of this year’s Student Entrepreneurship Programme
We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
The team behind MariTest, a non-invasive test for malaria, are the winners of this year’s Student Entrepreneurship Programme
Four internet-based therapies developed by experts at the University of Oxford’s Department of Experimental Psychology and Department of Psychiatry are proving helpful for patients with social anxiety disorder and post-traumatic stress disorders and for children with anxiety disorders.
A new company, MatchBio, founded by Professors Omer Dushek and Anton van der Merwe from the Dunn School of Pathology, is set to revolutionise immunotherapy by enhancing CAR T therapy.
Apollo Therapeutics will inject capital and expertise into pipeline of potentially lifesaving medicines through an agreement with the University of Oxford. The collaboration highlights a shared strategic intent to develop new therapeutics based on breakthroughs in biology and basic medical research at the University of Oxford.
An Oxford University spinout which supports accurate AI applications using Knowledge & Reasoning has been bought by Samsung Electronics.
Oxford University Innovation recently hosted two landmark events that brought together global investors, leading industry experts and innovative spinouts, showcasing the vibrant ecosystem of collaboration and cutting-edge technology at Oxford.
Amber Therapeutics successfully closed Series A funding of $100 million (£80 million) from leading healthcare and technology investors in the US and UK.
Discover why Clinical Outcome Assessments (COAs) are vital in clinical trials for measuring patient outcomes and ensuring reliable data for regulatory approval and improved patient care.
OUI's StEP Ignite student entrepreneurship programme 2024
Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on groundbreaking research from the MRC Weatherall Institute of Molecular Medicine at University of Oxford.